Patel Sanj K
SEC CIK 1532218 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | COB, CEO, Dir | 107.5K | — | $49.45M | 59 | 2022-03-16 | 2026-09-01 |
Most active insiders at KNSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sanj K | COB, CEO, Dir | — | $39.43M |
| 2 | Paolini John F. | Chief MEDICAL Off | — | $8.00M |
| 3 | Ragosa Mark | CFO | — | $5.56M |
| 4 | Tessari Eben | Chief STRATEGY Off | — | $3.10M |
| 5 | Quart Barry D | Dir | — | $2.68M |
| 6 | Megna Michael R | CAO | — | $2.64M |
| 7 | Cole G Bradley | Dir | — | $299.1K |
| 8 | Moat Ross | COO | — | $194.5K |
| 9 | McCain Tracey L | Dir | — | — |
| 10 | Levy Richard S | Dir | — | — |
Transactions 59
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-09-03 16:48 | 2026-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +31.3K | 107.5K | +41% | — |
| DI | 2026-09-03 16:48 | 2026-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $79.28 | -15.1K | 92.3K | -14% | -$1.20M |
| DMI | 2026-09-03 16:46 | 2026-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +31.3K | 107.5K | +41% | — |
| DI | 2026-09-03 16:46 | 2026-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $79.28 | -15.1K | 92.3K | -14% | -$1.20M |
| DI | 2026-06-02 16:50 | 2026-06-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | C - Cnv Deriv | — | +900.0K | 951.8K | +1,738% | — |
| DT | 2026-05-01 16:32 | 2026-05-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | $30.93 | +48.6K | 48.6K | New | +$1.50M |
| DT | 2026-05-01 16:32 | 2026-05-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $54.02 | -48.6K | 0 | -100% | -$2.62M |
| DMT | 2026-04-30 18:33 | 2026-04-28+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | $13.45 | +508.3K | 2,141 | New | +$6.84M |
| DMT | 2026-04-30 18:33 | 2026-04-28+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $51.96 | -508.3K | 0 | -100% | -$26.42M |
| DT | 2026-04-08 16:43 | 2026-04-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | $10.36 | +7,278 | 7,278 | New | +$75.4K |
| DT | 2026-04-08 16:43 | 2026-04-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $50.01 | -7,278 | 0 | -100% | -$364.0K |
| DTI | 2026-04-08 16:43 | 2026-04-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +9,991 | 81.0K | +14% | — |
| DTI | 2026-04-08 16:43 | 2026-04-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $48.94 | -4,831 | 76.2K | -6% | -$236.4K |
| DI | 2026-04-03 16:39 | 2026-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +21.3K | 81.3K | +36% | — |
| DI | 2026-04-03 16:39 | 2026-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $48.13 | -10.3K | 71.0K | -13% | -$496.4K |
| MI | 2025-11-14 | 2025-11-12+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | G - Gift | $0.00 | +111.8K | 60.0K | New | $0 |
| 2025-11-14 | 2025-11-12 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | G - Gift | $0.00 | -111.8K | 0 | -100% | $0 | |
| DM | 2025-10-22 | 2025-10-20+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | $3.80 | +258.0K | 209.2K | New | +$980.3K |
| DM | 2025-10-22 | 2025-10-20+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $38.86 | -258.0K | 111.8K | -70% | -$10.02M |
| DM | 2025-09-03 | 2025-09-01+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +29.3K | 119.4K | +32% | — |
| DM | 2025-09-03 | 2025-09-01+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $33.67 | -14.2K | 108.4K | -12% | -$476.7K |
| DM | 2025-05-28 | 2025-05-23+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +86.3K | 116.0K | +290% | +$137.2K |
| DM | 2025-05-28 | 2025-05-23+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $27.24 | -86.3K | 96.7K | -47% | -$2.35M |
| D | 2025-05-22 | 2025-05-20 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $27.02 | -2,349 | 96.7K | -2% | -$63.5K |
| D | 2025-05-22 | 2025-05-20 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +2,349 | 99.0K | +2% | +$3,735 |
| D | 2025-05-15 | 2025-05-13 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +2,872 | 99.5K | +3% | +$4,566 |
| D | 2025-05-15 | 2025-05-13 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $27.03 | -2,872 | 96.7K | -3% | -$77.6K |
| DM | 2025-05-09 | 2025-05-07+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $27.04 | -8,095 | 96.7K | -8% | -$218.9K |
| DM | 2025-05-09 | 2025-05-07+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +8,095 | 96.8K | +9% | +$12.9K |
| D | 2025-04-09 | 2025-04-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +9,992 | 101.5K | +11% | — |
| D | 2025-04-09 | 2025-04-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $20.28 | -4,832 | 96.7K | -5% | -$98.0K |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $21.77 | -5,321 | 94.5K | -5% | -$115.8K |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +12.7K | 90.6K | +16% | — |
| D | 2025-03-19 | 2025-03-16 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $22.61 | -2,004 | 84.1K | -2% | -$45.3K |
| D | 2025-03-19 | 2025-03-16 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +6,569 | 86.1K | +8% | — |
| D | 2024-11-08 | 2024-11-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +89.6K | 169.1K | +113% | +$142.4K |
| D | 2024-11-08 | 2024-11-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $23.00 | -89.6K | 79.6K | -53% | -$2.06M |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +23.0K | 82.7K | +39% | — |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $26.74 | -11.1K | 76.2K | -13% | -$298.0K |
| DM | 2024-07-25 | 2024-07-23 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $25.65 | -136.1K | 126.1K | -52% | -$3.49M |
| D | 2024-07-25 | 2024-07-23 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +136.1K | 199.1K | +216% | +$216.4K |
| D | 2024-04-08 | 2024-04-08 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $17.90 | -4,075 | 63.0K | -6% | -$72.9K |
| D | 2024-04-08 | 2024-04-08 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +9,992 | 67.1K | +18% | — |
| D | 2024-04-03 | 2024-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +6,482 | 59.0K | +12% | — |
| D | 2024-04-03 | 2024-04-01 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $19.70 | -1,903 | 57.1K | -3% | -$37.5K |
| I | 2024-03-11 | 2024-03-07 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale | $21.02 | -65.0K | 0 | -100% | -$1.37M |
| MI | 2024-03-06 | 2024-03-04+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | S - Sale | $21.34 | -18.3K | 65.0K | -22% | -$391.1K |
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +16.6K | 54.7K | +43% | — |
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $17.76 | -6,619 | 48.1K | -12% | -$117.6K |
| D | 2023-04-11 | 2023-04-10 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $10.71 | -2,933 | 42.6K | -6% | -$31.4K |
| D | 2023-04-11 | 2023-04-10 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +9,992 | 45.5K | +28% | — |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +18.6K | 39.0K | +91% | — |
| DM | 2023-03-20 | 2023-03-16+ | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $11.24 | -5,452 | 35.5K | -13% | -$61.3K |
| D | 2022-09-06 | 2022-09-02 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +6,569 | 24.3K | +37% | — |
| D | 2022-09-06 | 2022-09-02 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $11.44 | -1,929 | 22.4K | -8% | -$22.1K |
| D | 2022-03-23 | 2022-03-21 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $10.98 | -5,446 | 17.8K | -23% | -$59.8K |
| D | 2022-03-23 | 2022-03-21 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +18.6K | 23.2K | +399% | — |
| D | 2022-03-18 | 2022-03-16 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +6,569 | 6,569 | New | — |
| D | 2022-03-18 | 2022-03-16 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | COB, CEO, Dir | F - Tax | $10.13 | -1,922 | 4,647 | -29% | -$19.5K |
Purchase Sale Sale after option exercise All abbreviations